Thc Farmaceutica Stock Price, News & Analysis

THC Farmaceuticals Inc (OTC: CBDG) is an over-the-counter traded company based in Scottsdale, Arizona, specializing in the development and marketing of cannabidiol (CBD)-based products. The company operates through its subsidiary CBDual Biotechnology Corp, focusing on premium CBD-infused oral health and wellness products.

Business Focus

THC Farmaceuticals develops a unique line of CBD-based oral health products and anxiety management solutions. The company's product portfolio includes premium CBD oral health formulations and specialized anxiety relief products developed under proprietary formulations. The company emphasizes product quality and specialized therapeutic applications within the CBD wellness market.

Corporate History

Founded as an exploration and development stage company, THC Farmaceuticals has evolved to focus on CBD product development and commercialization. The company operates through CBDual Biotechnology Corp, its primary operating subsidiary, which handles product development and market distribution. In 2021, THC Farmaceuticals acquired controlling interest in G.K. Manufacturing from Cannabis Sativa, Inc., expanding its manufacturing and production capabilities within the CBD sector.

Product Portfolio

The company develops proprietary CBD oral health products designed for dental-related anxiety and general wellness applications. Dr. Rubin's branded products represent the company's flagship offerings in the CBD anxiety relief category. These products leverage CBD's recognized applications in wellness and anxiety management, marketed toward consumers seeking natural alternatives for oral health-related anxiety and general wellness support.

Manufacturing and Distribution

Through the acquisition of G.K. Manufacturing, THC Farmaceuticals enhanced its production capacity and manufacturing capabilities. The company manages product development, manufacturing, and distribution operations from its Scottsdale headquarters, serving the OTC market for CBD-based wellness products.

Market Position

As an OTC-traded company, THC Farmaceuticals operates in the over-the-counter market segment for CBD products. The company competes with numerous manufacturers in the rapidly evolving CBD wellness sector, which includes both established supplement companies and specialized CBD-focused enterprises. The OTC designation reflects the company's market positioning and regulatory framework for its products.

Leadership and Operations

The company was historically led by notable figures including Mike Gravel, who served as Chairman and CEO until his passing in 2021. The company maintains operations focused on product development, manufacturing partnerships, and direct distribution of its CBD-based wellness products to the consumer market.